Heligesic (orphenadrine + paracetamol): Uses, Dosage & Side Effects

What it's for (Indications)

Orphenadrine + paracetamol (acetaminophen) is indicated for the symptomatic relief of acute painful musculoskeletal conditions associated with muscle spasm.
This combination medication is employed when both a skeletal muscle relaxant and an analgesic are required to manage discomfort and improve functional mobility.
It is specifically designed for the treatment of conditions such as sprains, strains, low back pain, torticollis, tension headaches, and other acute painful conditions where involuntary muscle contractions contribute significantly to the patient's pain experience.
The orphenadrine component targets muscle spasm, while paracetamol provides effective pain relief, working synergistically to alleviate symptoms.
Treatment duration should generally be limited to the acute phase of the condition, and use should be under medical supervision to assess efficacy and minimize risks.

Dosage Information

Type	Guideline
Standard	The typical adult dosage for orphenadrine + paracetamol combination products usually involves administering one to two tablets, containing specific amounts of both active ingredients (e.g., 35 mg orphenadrine citrate and 450 mg paracetamol), orally, three to four times daily as needed for pain and muscle spasm. Dosage adjustments may be necessary based on individual patient response, severity of symptoms, and the patient's overall health status, particularly renal or hepatic function. The maximum daily dose for paracetamol should not exceed 4000 mg (4g) from all sources to prevent hepatotoxicity, and the total daily dose for orphenadrine should similarly not exceed recommended limits. It is crucial for patients to adhere strictly to the prescribed dosage and not exceed the maximum recommended daily intake of either component, especially paracetamol, without explicit medical advice. The medication should be taken with food or milk if gastrointestinal upset occurs.

Type

Guideline

Standard

The typical adult dosage for orphenadrine + paracetamol combination products usually involves administering one to two tablets, containing specific amounts of both active ingredients (e.g., 35 mg orphenadrine citrate and 450 mg paracetamol), orally, three to four times daily as needed for pain and muscle spasm. Dosage adjustments may be necessary based on individual patient response, severity of symptoms, and the patient's overall health status, particularly renal or hepatic function. The maximum daily dose for paracetamol should not exceed 4000 mg (4g) from all sources to prevent hepatotoxicity, and the total daily dose for orphenadrine should similarly not exceed recommended limits. It is crucial for patients to adhere strictly to the prescribed dosage and not exceed the maximum recommended daily intake of either component, especially paracetamol, without explicit medical advice. The medication should be taken with food or milk if gastrointestinal upset occurs.

Safety & Warnings

Common Side Effects

Common side effects associated with orphenadrine + paracetamol are largely attributable to the anticholinergic properties of orphenadrine and, less frequently, to paracetamol at therapeutic doses.
These include dose-related central nervous system effects such as drowsiness, dizziness, lightheadedness, and mild euphoria.
Anticholinergic effects may manifest as dry mouth, blurred vision, urinary retention, constipation, and tachycardia.
Gastrointestinal disturbances like nausea, vomiting, and dyspepsia can also occur.
Less common but more serious side effects can include palpitations, weakness, confusion, hallucinations, and allergic reactions (skin rash, pruritus, urticaria).
With paracetamol, especially in higher doses or chronic use, there is a risk of hepatotoxicity.
Patients should be advised to report any persistent or severe side effects, or signs of allergic reaction or liver problems (e.
g.
, dark urine, yellowing of skin/eyes, abdominal pain), to their healthcare provider immediately.

Serious Warnings

Black Box Warning: BLACK BOX WARNING: SEVERE LIVER INJURY AND ALLERGIC REACTIONS. Products containing paracetamol (acetaminophen), such as this combination, carry a significant risk of severe liver injury, including acute liver failure, which can be fatal. This risk is dose-dependent and is substantially increased when the maximum daily dose of paracetamol (4000 mg in 24 hours from all sources) is exceeded, or when used concomitantly with other paracetamol-containing products, or in individuals with pre-existing liver disease or chronic alcohol consumption. Healthcare professionals must advise patients against taking other medications containing paracetamol while on this therapy to avoid accidental overdose. Additionally, serious skin reactions, including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and acute generalized exanthematous pustulosis (AGEP), have been reported with paracetamol use. These reactions can be fatal. Patients should be instructed to discontinue the medication and seek immediate medical attention at the first appearance of skin rash, blisters, or any other sign of hypersensitivity or allergic reaction. Such reactions may occur without previous warning. The potential for these serious adverse events necessitates careful patient counseling and adherence to prescribed dosages.
Patients should be cautioned against the concomitant use of alcohol or other central nervous system depressants, as this may potentiate the sedative effects of orphenadrine, leading to increased drowsiness, dizziness, and impaired judgment, thus affecting the ability to drive or operate machinery safely.
Due to its anticholinergic properties, orphenadrine should be used with extreme caution in patients with known cardiac decompensation, coronary artery disease, or tachycardia.
Renal and hepatic impairment necessitate careful monitoring and potential dose adjustments, particularly given the metabolism of paracetamol.
Patients with a history of liver disease or chronic alcohol use are at increased risk of paracetamol-induced hepatotoxicity and should avoid exceeding recommended dosages.
This medication should not be used for prolonged periods without medical re-evaluation.
Patients should be advised to inform their healthcare provider of all concomitant medications to avoid potential drug interactions, especially with other paracetamol-containing products to prevent accidental overdose.

How it Works (Mechanism of Action)

The therapeutic effects of orphenadrine + paracetamol arise from the distinct mechanisms of its two active components. Orphenadrine is a centrally acting skeletal muscle relaxant. While its precise mechanism is not fully elucidated, it is believed to exert its effects primarily through its anticholinergic properties and possibly by modulating polysynaptic reflex arcs in the central nervous system, particularly within the reticular formation. It does not directly relax skeletal muscles or act on the motor endplate but rather reduces muscle spasm associated with acute painful musculoskeletal conditions. Paracetamol (acetaminophen) is an analgesic and antipyretic. Its mechanism of action is thought to involve the inhibition of prostaglandin synthesis within the central nervous system, likely by inhibiting cyclooxygenase (COX) enzymes, particularly COX-2 or a theoretical COX-3 variant. Unlike NSAIDs, paracetamol exhibits minimal anti-inflammatory activity peripherally, thus acting primarily to elevate the pain threshold and reduce fever without significant gastrointestinal or antiplatelet effects. The combination provides both muscle spasm relief and pain reduction.